Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
72.17
-0.54 (-0.74%)
At close: Oct 13, 2025, 4:00 PM EDT
72.17
0.00 (0.00%)
After-hours: Oct 13, 2025, 4:20 PM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $3.63 billion as of October 13, 2025. Its market cap has increased by 94.92% in one year.
Market Cap
3.63B
Enterprise Value
3.69B
1-Year Change
94.92%
Ranking
Category
Stock Price
$72.17
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $3.63B, an increase of 1,119.83%. That is a compound annual growth rate of 49.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 3.65B | 84.02% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | 510.71M | -7.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |